1. Increased Afterload Augments Sunitinib-Induced Cardiotoxicity in an Engineered Cardiac Microtissue Model
   Rachel Truitt et al, 2018, JACC: Basic to Translational Science CrossRef
2. Statin Use and Cancer Incidence in Patients with Type 2 Diabetes Mellitus: A Network Meta-Analysis
   Yi-Bing Hu et al, 2018, Gastroenterology Research and Practice CrossRef
3. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling
   Stefania Elena Navone et al, 2018, World Neurosurgery CrossRef
4. Analysis of Unstructured Data on Detecting of New Drug Indication of Atorvastatin
   Hwee-Soo Jeong et al, 2018, J Health Info Stat CrossRef
5. Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort Study.
   Charlotte Skriver et al, 2019, Ann Intern Med CrossRef
6. Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?
   Marek Z. Wojtukiewicz et al, 2017, Cancer Metastasis Rev CrossRef
7. Low-dose aspirin use and cancer-specific mortality: a meta-analysis of cohort studies
   Xianmin Wang et al, 2019 CrossRef
8. Salicylate suppresses the oncogenic hyaluronan network in metastatic breast cancer cells
   Theodoros T. Karalis et al, 2020, Matrix Biology Plus CrossRef
9. Attempts to use statins in cancer therapy: An update
   Lucyna Matusewicz et al, 2020, Tumour Biol. CrossRef
10. Revisiting prostate cancer metabolism: From metabolites to disease and therapy
    Henrique J. Cardoso et al, 2020, Med Res Rev CrossRef
11. STAT3 and p53: Dual Target for Cancer Therapy
    Thu-Huyen Pham et al, 2020, Biomedicines CrossRef
12. Aspirin Inhibits Cancer Metastasis and Angiogenesis via Targeting Heparanase.
    Xiaoyang Dai et al, 0 CrossRef
13. Network Pharmacology and Experimental Validation Reveal the Effects of Chidamide Combined With Aspirin on Acute Myeloid Leukemia-Myelodysplastic Syndrome Cells Through PI3K/AKT Pathway.
    Simin Liang et al, 2021, Front Cell Dev Biol CrossRef
14. TCF7L1 regulates cytokine response and neuroendocrine differentiation of prostate cancer
    Yu-Ching Wen et al, 2021, Oncogenesis CrossRef
15. Combined Effect of Metformin and Statin
    Sabu Mandumpal Chacko et al, 2021 CrossRef
16. Atorvastatin regulates the migration and invasion of prostate cancer through the epithelial-mesenchymal transformation and matrix metalloproteinase pathways
    Zhanmeng Zhu et al, 2022, Investig Clin Urol CrossRef
17. Identification of target and pathway of aspirin combined with Lipitor treatment in prostate cancer through integrated bioinformatics analysis
    Xiao Wang et al, 2022, Toxicology and Applied Pharmacology CrossRef
18. Atorvastatin inhibits the proliferation of MKN45-derived gastric cancer stem cells in a mevalonate pathway-independent manner
    Ye Seul Choi et al, 2022, Korean J Physiol Pharmacol CrossRef
19. Predicting the Physician’s Specialty Using a Medical Prescription Database
    Mahboube Akhlaghi et al, 2022, Computational and Mathematical Methods in Medicine CrossRef
20. Atorvastatin induces downregulation of matrix metalloproteinase-2/9 in MDA-MB-231 triple negative breast cancer cells
    Filiz Bakar-Ates et al, 2022, Med Oncol CrossRef
21. pH-Responsive Selenium Nanoplatform for Highly Efficient Cancer Starvation Therapy by Atorvastatin Delivery
    Jianmin Xiao et al, 2023, ACS Biomater. Sci. Eng. CrossRef
22. An Aminosteroid Derivative Shows Higher In Vitro and In Vivo Potencies than Gold Standard Drugs in Androgen-Dependent Prostate Cancer Models
    Donald Poirier et al, 2023, Cancers CrossRef
23. Lipid-lowering drugs and cancer: an updated perspective
    Azin Alizadehasl et al, 2023, Pharmacol. Rep CrossRef
24. Association of prophylactic low-dose aspirin use with all-cause and cause-specific mortality in cancer patients
    Hui Hu et al, 2024, Sci Rep CrossRef